Complete Filing Data
BrasilAgro - Brazilian Agricultural Real Estate Co reported Cash And Cash Equivalents of $142.91 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean BrasilAgro - Brazilian Agricultural Real Estate Co did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Profit Loss | $138.0M | $226.9M | $268.5M | $520.1M | $317.6M | $119.6M | $177.1M | $126.3M | $27.3M |
| Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -$1.4M | -$58.0K | -$70.0K | -$31.0K | $11.0K | -$150.0K | $1.1M | $14.7M | -$4.4M |
| Profit Loss From Operating Activities | $206.5M | $185.9M | $275.9M | $690.2M | $394.1M | $164.3M | $186.9M | $160.8M | -$185.0K |
| Other Comprehensive Income Net Of Tax Hedges Of Net Investments In Foreign Operations | -$7.5M | $54.8M | -$34.1M | $18.3M | -$35.9M | $76.5M | -$1.0M | $27.1M | $3.4M |
| Gross Profit | $338.2M | $311.9M | $393.7M | $775.9M | $491.5M | $221.4M | $236.2M | $155.7M | $47.9M |
| General And Administrative Expense | $67.5M | $65.5M | $65.8M | $56.0M | $46.9M | $43.9M | $38.8M | $34.9M | $30.9M |
| Cost Of Sales | $833.9M | $747.0M | $886.2M | $1.14B | $729.1M | $483.8M | $319.2M | $228.3M | $136.4M |
| Comprehensive Income | $130.6M | $281.6M | $234.5M | $538.4M | $281.7M | $196.0M | $176.1M | $122.8M | $30.7M |
| Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss | $47.7M | $50.8M | $22.7M | $4.2M | $2.0M | -$883.0K | $1.7M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $142.9M | $171.0M | $383.8M | $435.5M | $1.06B | $171.0M | $106.6M | $104.3M | $43.8M | $54.2M |
| Residual Value Of Property Plant And Equipment And Intangible Assets Disposed | $11.6M | $7.4M | $5.9M | $1.6M | $6.3M | $3.1M | $433.0K | $433.0K | $1.9M | |
| Redemption Of Investment In Marketable Securities | -$41.1M | -$40.6M | -$111.0M | $36.9M | -$2.8M | -$7.5M | -$21.7M | $4.0M | -$125.1M | |
| Gain On Remeasurement Of Receivable From Sale Of Farms Net | $15.7M | $72.9M | -$47.2M | $31.6M | $124.7M | $57.3M | $14.0M | $16.6M | $8.0M | |
| Deferred Income And Social Contribution Taxes | $32.7M | $58.8M | $40.1M | -$76.2M | $50.5M | -$3.5M | -$12.2M | -$21.0M | -$1.8M | |
| Changes In Fair Value Of Biological Assets And Agricultural Products | $122.7M | $40.5M | $78.2M | $549.8M | $527.3M | $160.4M | $56.7M | $99.1M | $12.3M | |
| Cash Flows From Used In Operating Activities | $71.5M | $79.4M | $155.7M | $205.2M | $117.4M | $60.4M | $51.3M | -$2.3M | $65.1M | |
| Cash Flows From Used In Investing Activities | -$38.9M | -$27.8M | $55.0M | -$89.7M | -$180.2M | -$20.7M | -$21.3M | -$65.7M | -$13.5M | |
| Cash Flows From Used In Financing Activities | -$60.7M | -$265.8M | -$261.1M | -$737.8M | $954.9M | $18.5M | -$27.6M | $125.4M | -$61.9M | |
| Adjustments For Increase Decrease In Trade Account Payable | $4.6M | -$28.7M | -$17.4M | -$57.9M | -$51.1M | -$59.9M | $10.0M | $1.7M | $25.0M | |
| Adjustments For Decrease Increase In Trade Account Receivable | -$35.9M | $7.5M | $44.7M | -$25.7M | $127.4M | $50.7M | $3.4M | -$6.7M | -$7.3M | |
| Adjustments For Decrease Increase In Derivative Financial Assets | $7.7M | $27.0M | -$2.1M | -$24.1M | -$5.8M | $3.9M | $19.3M | -$17.0M | $19.0M | |
| Adjustments For Decrease Increase In Biological Assets | $133.3M | $69.9M | $140.5M | $466.5M | $388.1M | $157.4M | $34.6M | $60.3M | $5.6M | |
| Property Plant And Equipment | $232.7M | $202.1M | $155.1M | $128.1M | $110.4M | $115.9M | $107.9M | $84.8M | $54.7M | |
| Liabilities | $1.66B | $1.43B | $1.31B | $1.13B | $1.25B | $922.8M | $477.1M | $423.7M | ||
| Assets | $3.84B | $3.61B | $3.51B | $3.35B | $3.43B | $2.04B | $1.36B | $1.18B | ||
| Current Biological Assets | $265.4M | $210.3M | $41.4K | $265.0M | $210.5M | $115.6M | $99.9M | $62.0M | ||
| Accumulated Other Comprehensive Income | $110.9M | $118.4M | $63.6M | $97.7M | $79.4M | $115.3M | $38.9M | $39.9M | ||
| Trade And Other Current Payables | $176.0M | $174.3M | $176.1M | $253.4M | $186.9M | $111.2M | $93.0M | $106.4M | ||
| Noncurrent Receivables | $603.8M | $588.5M | $486.8M | $411.4M | $348.9M | $262.4M | $203.5M | $74.8M | ||
| Noncurrent Payables | $46.8M | $36.7M | $31.4M | $23.8M | $34.9M | $28.0M | $19.5M | $11.3M | ||
| Noncurrent Liabilities | $1.00B | $898.1M | $679.0M | $645.2M | $584.4M | $522.7M | $250.5M | $220.6M | ||
| Noncurrent Derivative Financial Assets | $11.0M | $6.8M | $7.0M | $2.7M | $3.9M | $1.7M | $1.0M | $4.1M | ||
| Noncurrent Biological Assets | $32.3M | $26.9M | $37.3M | $57.9M | $34.6M | $25.4M | $23.2M | $34.1M | ||
| Noncurrent Assets | $2.66B | $2.51B | $2.16B | $1.76B | $1.67B | $1.40B | $916.8M | $807.3M | ||
| Equity And Liabilities | $3.84B | $3.61B | $3.51B | $3.35B | $3.43B | $2.04B | $1.36B | $1.18B | ||
| Deferred Tax Assets | $166.1M | $88.0M | $30.1M | $4.4M | $72.3M | $23.3M | $20.5M | $32.7M | ||
| Current Liabilities | $658.3M | $527.3M | $631.9M | $484.0M | $661.3M | $400.1M | $226.6M | $203.2M | ||
| Current Derivative Financial Liabilities | $15.5M | $69.2M | $22.0M | $34.1M | $48.6M | $18.3M | $11.1M | $10.5M | ||
| Current Derivative Financial Assets | $29.6M | $31.7M | $76.8M | $61.0M | $32.7M | $7.2M | $5.9M | $28.3M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Recoverable Taxes | -$10.4M | -$9.7M | -$14.6M | -$612.0K | -$23.8M | $3.8M | $536.0K | $1.9M | $2.8M |
| Increase Decrease In Cash And Cash Equivalents | -$28.1M | -$214.2M | -$50.3M | -$622.4M | $892.1M | $58.2M | $2.5M | $57.5M | -$10.4M |
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $28.0K | $1.3M | -$1.4M | -$1.3M | -$4.0M | $6.2M | -$138.0K | $3.1M | |
| Increase Decrease In Related Parties | -$567.0K | $364.0K | -$3.2M | -$440.0K | $276.0K | -$2.3M | $16.7M | ||
| Increase Decrease In Other Receivable | -$36.8M | $56.4M | -$31.6M | $21.2M | -$316.0K | -$2.4M | $3.8M | ||
| Increase Decrease In Other Liability | -$25.9M | $5.7M | $657.0K | -$6.7M | $542.0K | $115.0K | -$1.3M | ||
| Increase Decrease In Advances From Customers | $108.0K | -$2.8M | $5.0M | $212.0K | $15.5M | $15.5M | $5.4M | ||
| Increase Decrease In Accrued Income Tax Payable | $14.7M | $17.5M | $30.8M | $31.1M | $3.2M | $1.7M | -$2.8M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Diluted Earnings Loss Per Share | $1.38 | $2.27 | $2.70 | $5.23 | $4.45 | $2.09 | $3.27 | $2.35 | $0.47 |
| Basic Earnings Loss Per Share | $1.39 | $2.28 | $2.72 | $5.26 | $4.56 | $2.11 | $3.29 | $2.35 | $0.48 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Adjustments For Decrease Increase In Inventories | -$137.4M | -$59.4M | $1.4M | -$74.4M | -$154.9M | -$43.3M | -$31.1M | -$58.4M | -$6.3M |
| Investment Property | $1.32B | $1.33B | $1.25B | $1.00B | $997.1M | $858.3M | $548.7M | $557.2M | $389.8M |
| Unrealized Gain Loss On Derivatives Net | $63.7M | -$82.6M | $34.5M | $14.2M | -$9.0M | -$7.5M | -$4.5M | $1.8M | $1.5M |
| Unrealized Foreign Exchange Loss Monetary Variation And Financial Charges Net | -$112.0M | -$41.2M | -$22.3M | -$18.8M | -$100.8M | -$42.3M | -$15.4M | -$16.1M | $8.5M |
| Selling Expense | $59.5M | $55.1M | $41.0M | $43.6M | $28.0M | $14.3M | $10.5M | $10.1M | $6.7M |
| Reclassification Adjustments On Exchange Differences On Translation Net Of Tax | -$7.5M | $54.8M | -$34.1M | $18.3M | -$35.9M | $76.5M | -$1.0M | $27.1M | $3.4M |
| Provision Reversal Of Provision For Legal Claims | -$331.0K | $437.0K | -$2.2M | -$19.0K | -$1.4M | -$601.0K | $383.0K | $387.0K | -$139.0K |
| Profit Before Income And Social Contribution Taxes | $124.6M | $191.5M | $281.7M | $637.3M | $298.1M | $133.5M | $199.8M | $152.3M | $33.3M |
| Other Operating Income Expense | -$4.8M | -$5.4M | -$11.0M | $13.8M | -$22.6M | $1.2M | -$1.1M | $35.4M | -$6.0M |
| Minimum Mandatory Dividends | -$32.8M | -$53.9M | -$63.8M | -$123.5M | -$75.4M | -$28.4M | -$42.1M | -$30.0M | -$6.5M |
| Income And Social Contribution Taxes | -$13.4M | -$35.4M | $13.2M | $117.2M | -$19.5M | $14.0M | $22.7M | $25.9M | $5.9M |
| Finance Income | $337.5M | $312.9M | $330.5M | $320.2M | $849.6M | $375.4M | $310.5M | $129.3M | $110.1M |
| Finance Costs | $417.9M | $307.2M | $324.6M | $373.0M | $945.6M | $406.2M | $297.6M | $137.9M | $76.6M |
| Dividends Paid Classified As Financing Activities | $156.0M | $319.1M | $320.0M | $460.0M | $42.0M | $50.0M | $41.0M | $13.0M | $32.0M |
| Gain On Sale Of Farms | $180.1M | $248.4M | $346.1M | $251.5M | $53.1M | $61.4M | $142.8M | $39.8M | $26.7M |
| Gain On Sale Of Farm | $180.1M | $194.8M | $306.5M | $140.7M | $31.7M | $45.9M | $142.8M | $39.8M | $26.7M |
| Provision For Doubtful Account | -$203.0K | $2.1M | $20.0K | $151.0K | -$2.4M | -$530.0K | -$133.0K | -$516.0K | |
| Payment Of Additional Dividends | -$196.5M | -$184.6M | -$13.6M | -$7.9M | -$11.0M | -$6.5M | -$29.5M | ||
| Increase Decrease Through Sharebased Payment Transactions | $1.4M | -$1.2M | $10.6M | $3.2M | $2.6M | $3.5M | $1.6M | $844.0K | |
| Adjustments For Sharebased Payments | $1.4M | $1.8M | $5.9M | $3.2M | $2.6M | $1.5M | $1.6M | $844.0K | |
| Writeoff Reversal Of Capitalized Costs Investment Propertie | $466.0K | -$1.5M | $733.0K | $6.7M | $600.0K | $10.8M | $8.2M | ||
| Increase Decease In Labor Obligations | $2.1M | -$3.0M | -$2.9M | $2.7M | -$2.8M | $2.8M | $2.7M | ||
| Treasury Shares | 43.6M | 43.6M | 50.8M | 49.8M | 40.1M | 31.5M | 35.2M | 35.2M | |
| Longterm Legal Proceedings Provision | $792.0K | $699.0K | $1.3M | $1.1M | $1.4M | $1.5M | $824.0K | $1.2M | |
| Longterm Borrowings | $529.7M | $504.6M | $356.4M | $329.6M | $341.1M | $296.8M | $209.2M | $187.4M | |
| Issued Capital | $1.59B | $1.59B | $1.59B | $1.59B | $1.59B | $699.8M | $584.2M | $584.2M | |
| Inventories | $293.5M | $233.5M | $213.7M | $289.9M | $265.9M | $138.8M | $97.1M | $69.6M | |
| Current Provisions For Employee Benefits | $21.5M | $20.7M | $23.4M | $25.7M | $22.5M | $19.6M | $17.1M | $14.3M | |
| Current Borrowings And Current Portion Of Noncurrent Borrowings | $355.8M | $177.3M | $198.2M | $123.4M | $322.0M | $217.3M | $76.6M | $68.4M |
Most recent annual filing with the SEC: October 30, 2025
Data sourced from SEC EDGAR public filings as of August 4, 2026.